title: The OECD program to validate the rat uterotrophic bioassay. Phase 2: dose-response studies.
abstract: The Organisation for Economic Co-operation and Development has completed phase 2 of an international validation program for the rodent uterotrophic bioassay. The purpose of the validation program was to demonstrate the performance of two versions of the uterotrophic bioassay, the immature female rat and the adult ovariectomized rat, in four standardized protocols. This article reports the dose-response studies of the validation program; the coded single-dose studies are reported in an accompanying paper. The dose-response study design used five selected weak estrogen agonists, bisphenol A, genistein, methoxychlor, nonylphenol, and o,p -DDT. These weak agonists were administered in a prescribed series of doses to measure the performance and reproducibility of the protocols among the participating laboratories. All protocols successfully detected increases in uterine weights when the weak agonists were administered. Within each protocol, there was good agreement and reproducibility of the dose response among laboratories with each substance. Substance-specific variations were observed in the influence of the route of administration on the uterine response, the potency as related to the dose producing the first statistically significant increase in uterine weights, and the maximum increase in uterine weight. Substantive performance differences were not observed between the uterotrophic bioassay versions or among the standardized protocols, and these were judged to be qualitatively equivalent. It is noteworthy that these results were reproducible under a variety of different experimental conditions (e.g., animal strain, diet, housing, bedding, vehicle, animal age), indicating that the bioassay's performance as a screen is robust. In conclusion, both the intact, immature, and adult OVX versions, and all protocols appear to be reproducible and transferable across laboratories and are able to detect weak estrogen agonists.
authors.affiliation: National Institute of Health Sciences, Tokyo, Japan.
authors.forename: Jun
authors.initials: J
authors.lastname: Kanno
authors.forename: Lesley
authors.initials: L
authors.lastname: Onyon
authors.forename: Shyamal
authors.initials: S
authors.lastname: Peddada
authors.forename: John
authors.initials: J
authors.lastname: Ashby
authors.forename: Elard
authors.initials: E
authors.lastname: Jacob
authors.forename: William
authors.initials: W
authors.lastname: Owens
mesh_terms: D000367:Age Factors; D000821:Animal Feed; D000818:Animals; D001681:Biological Assay / Q000592:standards; D004305:Dose-Response Relationship, Drug; D004703:Endocrine System / Q000187:drug effects; D004785:Environmental Pollutants / Q000633:toxicity*; D005260:Female; D006799:Housing, Animal; D006801:Humans; D007753:Laboratories / Q000592:standards; D015588:Observer Variation; D010052:Ovariectomy / Q000662:veterinary; D015203:Reproducibility of Results; D012107:Research Design; D014599:Uterus / Q000254:growth & development* / Q000473:pathology*
chemical_list: D004785:Environmental Pollutants